Nanotechnology in the diagnosis and treatment of lung cancer

AM Cryer, AJ Thorley - Pharmacology & therapeutics, 2019 - Elsevier
Lung cancer is an umbrella term for a subset of heterogeneous diseases that are collectively
responsible for the most cancer-related deaths worldwide. Despite the tremendous progress …

Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate

SD Rosen, H Lemjabbar-Alaoui - Expert opinion on therapeutic …, 2010 - Taylor & Francis
Importance of the field: Sulf-1 and Sulf-2 are sulfatases that edit the sulfation status of
heparan sulfate proteoglycans (HSPGs) on the outside of cells and regulate a number of …

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

R Bueno, EW Stawiski, LD Goldstein, S Durinck… - Nature …, 2016 - nature.com
Abstract We analyzed transcriptomes (n= 211), whole exomes (n= 99) and targeted exomes
(n= 103) from 216 malignant pleural mesothelioma (MPM) tumors. Using RNA-seq data, we …

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

Y Blum, C Meiller, L Quetel, N Elarouci, M Ayadi… - Nature …, 2019 - nature.com
Malignant pleural mesothelioma (MPM) is recognized as heterogeneous based both on
histology and molecular profiling. Histology addresses inter-tumor and intra-tumor …

[HTML][HTML] Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines …

C Tripathi, BN Tewari, RK Kanchan, KS Baghel… - Oncotarget, 2014 - ncbi.nlm.nih.gov
TAMs, a unique and distinct M2-skewed myeloid population of tumor stroma, exhibiting pro-
tumor functions is fast emerging as a potential target for anti-cancer immunotherapy …

Activation of tumor-cell STING primes NK-cell therapy

EH Knelson, EV Ivanova, M Tarannum… - Cancer immunology …, 2022 - AACR
Activation of the stimulator of interferon genes (STING) pathway promotes antitumor
immunity but STING agonists have yet to achieve clinical success. Increased understanding …

Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical …

F López-Ríos, S Chuai, R Flores, S Shimizu, T Ohno… - Cancer research, 2006 - AACR
Most gene expression profiling studies of mesothelioma have been based on relatively
small sample numbers, limiting their statistical power. We did Affymetrix U133A microarray …

Revealing global regulatory perturbations across human cancers

H Goodarzi, O Elemento, S Tavazoie - Molecular cell, 2009 - cell.com
The discovery of pathways and regulatory networks whose perturbation contributes to
neoplastic transformation remains a fundamental challenge for cancer biology. We show …

The immune microenvironment in mesothelioma: mechanisms of resistance to immunotherapy

GJ Chu, N Van Zandwijk, JEJ Rasko - Frontiers in Oncology, 2019 - frontiersin.org
Although mesothelioma is the consequence of a protracted immune response to asbestos
fibers and characterized by a clear immune infiltrate, novel immunotherapy approaches …

Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition

A De Reynies, MC Jaurand, A Renier, G Couchy… - Clinical Cancer …, 2014 - AACR
Purpose: Despite research efforts to develop more effective diagnostic and therapeutic
approaches, malignant pleural mesothelioma (MPM) prognosis remains poor. The …